Related Experiment Video

Updated: Feb 23, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.1K

A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancer

L Gasa1, A Sanchez-Botet1, E Quandt1

  • 1Faculty of Medicine and Health Sciences, Universitat Internacional de Catalunya, Barcelona, Spain.

Scientific Reports
|September 2, 2017
PubMed

Insights

New research identifies CNTD2 as a significant oncogenic driver in lung cancer. Overexpression of this cyclin promotes cancer cell growth and migration, suggesting its potential as a prognostic biomarker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Lung cancer is a leading cause of cancer death globally, with a need for better prognostic biomarkers and targeted treatments.
  • Core cyclins are known oncogenes in lung cancer, driving cell proliferation.
  • The oncogenic potential of newly identified atypical cyclins in lung cancer requires investigation.

Purpose of the Study:

  • To investigate the protein levels and functional roles of eight atypical cyclins in lung cancer.
  • To determine if novel cyclins contribute to lung cancer development and progression.

Main Methods:

  • Protein levels of eight atypical cyclins were analyzed in lung cancer cell lines and formalin-fixed, paraffin-embedded (FFPE) human tumors.
  • Functional roles were assessed in lung cancer cells, including viability, proliferation (Ki-67), clonogenicity, and migration assays.
  • In vivo tumor growth was evaluated using A549 xenograft models.
  • Gene expression data was analyzed for correlations between CNTD2 levels and patient survival.

Main Results:

  • Cyclin-dependent kinase andnotin-like domain containing 2 (CNTD2) was significantly overexpressed in lung cancer compared to normal tissue, with nuclear localization.
  • CNTD2 overexpression enhanced lung cancer cell viability, Ki-67 intensity, clonogenicity, and migration.
  • CNTD2 promoted tumor growth in vivo in A549 xenograft models.
  • Elevated CNTD2 levels correlated with decreased overall survival in lung cancer patients.

Conclusions:

  • CNTD2 acts as a novel oncogenic driver in lung cancer.
  • CNTD2 demonstrates potential as a prognostic biomarker for lung cancer.
  • CNTD2 represents a promising therapeutic target for lung cancer treatment.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K
The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

114.0K

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.7K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K